Literature DB >> 22948980

Glycine transporter-1 inhibition preceding extinction training inhibits reacquisition of cocaine seeking.

Cindy Achat-Mendes1, Bríd Á Nic Dhonnchadha, Donna M Platt, Kathleen M Kantak, Roger D Spealman.   

Abstract

Cognitive enhancers that act by increasing glycine transmission might be useful adjuncts to cocaine-cue extinction training to deter relapse. The study investigated the effects of combining treatments of the glycine transporter-1 (GlyT-1) inhibitor, Org24598, with extinction training on the subsequent reacquisition of cocaine self-administration. Squirrel monkeys and rats were trained to self-administer cocaine under a second-order schedule of intravenous drug injection in which responding was maintained by cocaine injections and a cocaine-paired visual stimulus. During three weekly extinction sessions, saline was substituted for cocaine but responding still produced the cocaine-paired stimulus. Subjects were treated with Org24598 or vehicle, either before or after each extinction session. One week later, cocaine injections were restored, and reacquisition of cocaine self-administration was evaluated over 15 sessions. Compared with vehicle, administration of Org24598 (1.0 mg/kg in monkeys; 3.0 or 7.5 mg/kg in rats) before each extinction session significantly inhibited reacquisition of cocaine self-administration in each species. In contrast, administration of Org24598 (1.0 mg/kg in monkeys) following, rather than preceding, each extinction session did not affect reacquisition compared with vehicle. When extinction training was replaced by cocaine self-administration or abstinence control conditions, treatment with the same doses of Org24598 resulted in reacquisition that was significantly more rapid than the reacquisition observed when Org24598 was administered before extinction training sessions. The results support the potential clinical utility of GlyT-1 inhibitor pretreatments combined with cocaine-cue extinction training to inhibit relapse.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948980      PMCID: PMC3499725          DOI: 10.1038/npp.2012.155

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  38 in total

Review 1.  Incentive-sensitization and addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Addiction       Date:  2001-01       Impact factor: 6.526

2.  Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving.

Authors:  Dean F Wong; Hiroto Kuwabara; David J Schretlen; Katherine R Bonson; Yun Zhou; Ayon Nandi; James R Brasić; Alane S Kimes; Marika A Maris; Anil Kumar; Carlo Contoreggi; Jonathan Links; Monique Ernst; Olivier Rousset; Stephen Zukin; Anthony A Grace; Jae Sung Lee; Charles Rohde; Donald R Jasinski; Albert Gjedde; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2006-09-13       Impact factor: 7.853

3.  Models of neurological disease (substance abuse): self-administration in monkeys.

Authors:  Donna M Platt; Galen Carey; Roger D Spealman
Journal:  Curr Protoc Pharmacol       Date:  2011-12

4.  Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.

Authors:  Stephanie S O'Malley; Rajita Sinha; Carlos M Grilo; Christy Capone; Conor K Farren; Sherry A McKee; Bruce J Rounsaville; Ran Wu
Journal:  Alcohol Clin Exp Res       Date:  2007-04       Impact factor: 3.455

5.  Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Jean Logan; Anna-Rose Childress; Millard Jayne; Yeming Ma; Christopher Wong
Journal:  J Neurosci       Date:  2006-06-14       Impact factor: 6.167

6.  ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter.

Authors:  B N Atkinson; S C Bell; M De Vivo; L R Kowalski; S M Lechner; V I Ognyanov; C S Tham; C Tsai; J Jia; D Ashton; M A Klitenick
Journal:  Mol Pharmacol       Date:  2001-12       Impact factor: 4.436

Review 7.  Drug targets for cognitive enhancement in neuropsychiatric disorders.

Authors:  Tanya L Wallace; Theresa M Ballard; Bruno Pouzet; Wim J Riedel; Joseph G Wettstein
Journal:  Pharmacol Biochem Behav       Date:  2011-04-01       Impact factor: 3.533

Review 8.  Glutamate receptors in extinction and extinction-based therapies for psychiatric illness.

Authors:  Karyn M Myers; William A Carlezon; Michael Davis
Journal:  Neuropsychopharmacology       Date:  2010-07-14       Impact factor: 7.853

9.  Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo.

Authors:  Long Chen; Mark Muhlhauser; Charles R Yang
Journal:  J Neurophysiol       Date:  2003-02       Impact factor: 2.714

10.  Dopaminergic response to drug words in cocaine addiction.

Authors:  Rita Z Goldstein; Dardo Tomasi; Nelly Alia-Klein; Jean Honorio Carrillo; Thomas Maloney; Patricia A Woicik; Ruiliang Wang; Frank Telang; Nora D Volkow
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

View more
  9 in total

1.  GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders.

Authors:  Jared W Young; Mary E Kamenski; Kerin K Higa; Gregory A Light; Mark A Geyer; Xianjin Zhou
Journal:  Neuropsychopharmacology       Date:  2015-04-24       Impact factor: 7.853

2.  Environmental enrichment facilitates cocaine-cue extinction, deters reacquisition of cocaine self-administration and alters AMPAR GluA1 expression and phosphorylation.

Authors:  Jamie M Gauthier; Amy Lin; Bríd Á Nic Dhonnchadha; Roger D Spealman; Heng-Ye Man; Kathleen M Kantak
Journal:  Addict Biol       Date:  2015-09-18       Impact factor: 4.280

3.  Cocaine-seeking behavior in a genetic model of attention-deficit/hyperactivity disorder following adolescent methylphenidate or atomoxetine treatments.

Authors:  Chloe J Jordan; Roxann C Harvey; Britahny B Baskin; Linda P Dwoskin; Kathleen M Kantak
Journal:  Drug Alcohol Depend       Date:  2014-04-28       Impact factor: 4.492

4.  Sex differences in the effects of a combined behavioral and pharmacological treatment strategy for cocaine relapse prevention in an animal model of cue exposure therapy.

Authors:  Kathleen M Kantak; Jamie M Gauthier; Elon Mathieson; Eudokia Knyazhanskaya; Pedro Rodriguez-Echemendia; Heng-Ye Man
Journal:  Behav Brain Res       Date:  2020-08-02       Impact factor: 3.332

5.  Recent developments in animal models of drug relapse.

Authors:  Nathan J Marchant; Xuan Li; Yavin Shaham
Journal:  Curr Opin Neurobiol       Date:  2013-01-29       Impact factor: 6.627

6.  Cocaine Experience Enhances Thalamo-Accumbens N-Methyl-D-Aspartate Receptor Function.

Authors:  Max E Joffe; Brad A Grueter
Journal:  Biol Psychiatry       Date:  2016-04-07       Impact factor: 13.382

7.  Facilitative effects of environmental enrichment for cocaine relapse prevention are dependent on extinction training context and involve increased TrkB signaling in dorsal hippocampus and ventromedial prefrontal cortex.

Authors:  Margaret H Hastings; Jamie M Gauthier; Kyle Mabry; Audrey Tran; Heng-Ye Man; Kathleen M Kantak
Journal:  Behav Brain Res       Date:  2020-03-16       Impact factor: 3.332

Review 8.  Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.

Authors:  Robert J Harvey; Benjamin K Yee
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

9.  Screening for New Inhibitors of Glycine Transporter 1 and 2 by Means of MS Binding Assays.

Authors:  Thomas M Ackermann; Georg Höfner; Klaus T Wanner
Journal:  ChemMedChem       Date:  2021-07-28       Impact factor: 3.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.